Nucleic Acids Research, 2001, Vol. 29, No. 17 3477-3486
© 2001 Oxford University Press
Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs
University Medical Center Utrecht, Department of Physiological Chemistry, Stratenum, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands
Human insulin-like growth factor II (IGF-II) mRNA can be cleaved at a specific site in its 4 kb long 3'-UTR. This yields a stable 3' cleavage product of 1.8 kb consisting of a 3'-UTR and a poly(A) tail and an unstable 5' cleavage product containing the IGF-II coding region. After cleavage, the 5' cleavage product is targeted to rapid degradation and consequently is no longer involved in IGF-II protein synthesis. Cleavage is therefore thought to provide an additional way to control IGF-II gene expression. In this paper the kinetics and the efficiency of cleavage of IGF-II mRNAs are examined. The cleavage efficiency of IGF-II mRNAs carrying four different leaders (L1L4) is enhanced in the highly structured leaders L1 and L3. Additionally, under standard cell culture conditions cleavage is a slow process that only plays a limited role in destabilisation and translation of the IGF-II mRNAs. However, in human Hep3B cells and CaCo2 cells which express IGF-II endogenously, cleavage is upregulated 35-fold at high cell densities. Regulated endonucleolytic cleavage of IGF-II mRNAs is restricted to cells in which IGF-II expression is related to specific cell processes.
* To whom correspondence should be addressed. Tel: +31 30 2538966; Fax: +31 30 2539035; Email: p.holthuizen{at}med.uu.nl
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A.-L. Finoux and B. Seraphin In Vivo Targeting of the Yeast Pop2 Deadenylase Subunit to Reporter Transcripts Induces Their Rapid Degradation and Generates New Decay Intermediates J. Biol. Chem., September 8, 2006; 281(36): 25940 - 25947. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zekri, K. Chebli, H. Tourriere, F. C. Nielsen, T. V. O. Hansen, A. Rami, and J. Tazi Control of Fetal Growth and Neonatal Survival by the RasGAP-Associated Endoribonuclease G3BP Mol. Cell. Biol., October 1, 2005; 25(19): 8703 - 8716. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liao, M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells J. Biol. Chem., November 19, 2004; 279(47): 48716 - 48724. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cougot, S. Babajko, and B. Seraphin Cytoplasmic foci are sites of mRNA decay in human cells J. Cell Biol., April 12, 2004; 165(1): 31 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, P. E. Holthuizen, H. S. Park, Y. L. Ha, K. C. Jung, and J. H. Y. Park Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G357 - G367. [Abstract] [Full Text] [PDF] |
||||



